[ Price : $8.95]
The FDA Rare Disease Innovation Hub sets eight action items for 2026.[ Price : $8.95]
FDA accepts for priority review a Bristol Myers Squibb NDA for iberdomide in combination with daratumumab and dexamethasone for pa...[ Price : $8.95]
FDAs refusal to review Modernas mRNA influenza vaccine reignites concerns that vaccine policy particularly involving mRNA technol...[ Price : $8.95]
The Center for Veterinary Medicine warns Elanco Animal Health about false and misleading claims in promotional materials for its P...[ Price : $8.95]
FDA warns Australias Cosmetics Manufacturers about CGMP violations in its production of drugs as a contract manufacturer.[ Price : $8.95]
Compass Pathways reports that its investigational psilocybin therapy met the primary endpoint in a second pivotal Phase 3 trial fo...[ Price : $8.95]
An FDA Early Alert says Trividia Health has issued updated use instructions for its True Metrix blood glucose monitors to emphasiz...[ Price : $8.95]
The Senate HELP Committee offers an initial 15 recommendations for reforming FDA as part of what it says will be a collaborative, ...